Researchers at the Medical College of Georgia are preparing to start the first FDA-approved clinical study of the effectiveness of using umbilical cord-blood stem cells as treatment for cerebral palsy. The trial will involve 40 patients ages 2 to 12. Doctors will examine the patients for improvements three months, six months and nine months into the trial.

Full Story:
Disability Scoop

Related Summaries